LongJuvity

LongJuvity is a pre-clinical stage biotechnology company focused on identifying and developing systemic factors that regulate the aging process. Founded by pioneers in longevity research, Dr. Nir Barzilai and Dr. Thomas Rando, the company leverages insights from heterochronic parabiosis and proteomics to discover rejuvenating proteins and molecules. Their goal is to develop therapeutics that can reverse or slow age-related decline across multiple organ systems by modulating the systemic environment. LongJuvity's platform targets aging as a primary risk factor for chronic diseases, aiming to address conditions such as sarcopenia and neurodegeneration. The company represents a significant effort to translate geroscience into a new class of systemic medicines.